GGrantIndex
← Leaderboards

Joanne E Curran

University Of Texas Rio Grande Valley

$13,045,119
Attributed
$26,353,044
Total exposure
8
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4M · FY200725
$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$26,353,044 · 8

By mechanism

R01$19,372,698 · 6
RM1$4,934,544 · 1
U54$2,045,802 · 1

Top collaborators

Most similar at University Of Texas Rio Grande Valley

Same institution · by research overlap

Others in their field

Top investigators on “Genetic

Research focus

GeneticPhenotypeGenesMexican AmericansGenotypeSamplingVariantTraitPathway InteractionsRisk FactorsGenetic PedigreeBaseDisorder RiskFamily StudyEconomic BurdenDisease SusceptibilityHeritabilityUnited StatesObesityLife StyleParticipantPredispositionComplexCohort

Grant awards (37)

Experimental Cellular Approaches to Genotype × Environment Interaction$1,597,684
RM1 · FY2025 · GM · contact PI
Research Project 1 - Hepatocellular Genetic Epidemiology of Fatty Liver Disease in Hispanics$648,026
U54 · FY2025 · HG · contact PI
Experimental Cellular Approaches to Genotype × Environment Interaction$61,342
RM1 · FY2025 · GM · contact PI
Experimental Cellular Approaches to Genotype × Environment Interaction$46,007
RM1 · FY2025 · GM · contact PI
Experimental Cellular Approaches to Genotype × Environment Interaction$1,611,736
RM1 · FY2024 · GM · contact PI
Research Project 1 - Hepatocellular Genetic Epidemiology of Fatty Liver Disease in Hispanics$658,576
U54 · FY2024 · HG · contact PI
Assessing the Influence of the Human Lipidome on Risk of Diabetes in a Minority Population$500,383
R01 · FY2024 · DK · contact PI
Experimental Cellular Approaches to Genotype × Environment Interaction$1,617,775
RM1 · FY2023 · GM · contact PI
Research Project 1 - Hepatocellular Genetic Epidemiology of Fatty Liver Disease in Hispanics$739,200
U54 · FY2023 · HG · contact PI
Assessing the Influence of the Human Lipidome on Risk of Diabetes in a Minority Population$525,583
R01 · FY2023 · DK · contact PI
Assessing the Influence of the Human Lipidome on Risk of Diabetes in a Minority Population$369,720
R01 · FY2023 · DK · contact PI
Assessing the Influence of the Human Lipidome on Risk of Diabetes in a Minority Population$552,650
R01 · FY2022 · DK · contact PI
Assessing the Influence of the Human Lipidome on Risk of Diabetes in a Minority Population$204,536
R01 · FY2022 · DK · contact PI
Genetic Determinants of Lipidomic Variation and Their Role in CVD Risk$589,915
R01 · FY2021 · HL · contact PI
Assessing the Influence of the Human Lipidome on Risk of Diabetes in a Minority Population$563,496
R01 · FY2021 · DK · contact PI
Genetic Determinants of Lipidomic Variation and Their Role in CVD Risk$616,156
R01 · FY2020 · HL · contact PI
Telomere Length Dynamics in Relation to Changes in Adiposity and Metabolic Risk$486,738
R01 · FY2020 · DK
Genetic Determinants of Lipidomic Variation and Their Role in CVD Risk$567,992
R01 · FY2019 · HL · contact PI
Telomere Length Dynamics in Relation to Changes in Adiposity and Metabolic Risk$507,208
R01 · FY2019 · DK
Genetic Determinants of Lipidomic Variation and Their Role in CVD Risk$585,642
R01 · FY2018 · HL · contact PI
Telomere Length Dynamics in Relation to Changes in Adiposity and Metabolic Risk$506,851
R01 · FY2018 · DK
Telomere Length Dynamics in Relation to Changes in Adiposity and Metabolic Risk$552,999
R01 · FY2017 · DK
Whole Genome Sequencing to Identify Causal Genetic Variants Influencing CVD Risk$961,969
R01 · FY2016 · HL
Telomere Length Dynamics in Relation to Changes in Adiposity and Metabolic Risk$658,770
R01 · FY2016 · DK
Whole Genome Sequencing to Identify Causal Genetic Variants Influencing CVD Risk$1,124,029
R01 · FY2015 · HL
Whole Genome Sequencing to Identify Causal Genetic Variants Influencing CVD Risk$2,673,849
R01 · FY2014 · HL
Whole Genome Sequencing to Identify Causal Genetic Variants Influencing CVD Risk$1,351,969
R01 · FY2014 · HL
Whole Genome Sequencing to Identify Causal Genetic Variants Influencing CVD Risk$1,468,531
R01 · FY2013 · HL
Whole Genome Sequencing to Identify Causal Genetic Variants Influencing CVD Risk$618,608
R01 · FY2012 · HL
Identification of Regulatory Variants in Novel Candidate Genes for Diabetes$329,294
R01 · FY2011 · DK · contact PI
Expression-Based Empirical Candidate Genes Influencing Body Mass Index$830,995
R01 · FY2010 · DK · contact PI
Identification of Regulatory Variants in Novel Candidate Genes for Diabetes$333,323
R01 · FY2010 · DK · contact PI
Expression-Based Empirical Candidate Genes Influencing Body Mass Index$853,485
R01 · FY2009 · DK · contact PI
Identification of Regulatory Variants in Novel Candidate Genes for Diabetes$337,378
R01 · FY2009 · DK · contact PI
Identification of Regulatory Variants in Novel Candidate Genes for Diabetes$1,710
R01 · FY2009 · DK · contact PI
Identification of Regulatory Variants in Novel Candidate Genes for Diabetes$338,046
R01 · FY2008 · DK · contact PI
Identification of Regulatory Variants in Novel Candidate Genes for Diabetes$360,873
R01 · FY2007 · DK · contact PI